{
    "root": "313fc382-3a8a-9769-e063-6294a90a453c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Oxybutynin Chloride",
    "value": "20250326",
    "ingredients": [
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "OXYBUTYNIN CHLORIDE",
            "code": "L9F3D9RENQ"
        }
    ],
    "indications": "Oxybutynin chloride tablets are indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).",
    "contraindications": null,
    "warningsAndPrecautions": "Oxybutynin Chloride Tablets USP, 5 mg, are round, light blue, scored tablets debossed \"4853\" and \"V\" on one side separated by a horizontal score and plain on the reverse side. The tablets are supplied as follows:\n  \nUnit dose packages of 100 (10 x 10) NDC 60687-670-01\n \n                  Store at 20째 to 25째C (68째 to 77째F) [see USP Controlled Room Temperature].\n                  \n                     FOR YOUR PROTECTION: Do not use if blister is torn or broken.",
    "adverseReactions": "Oxybutynin chloride is contraindicated in patients with urinary retention, gastric retention and other severe decreased gastrointestinal motility conditions, uncontrolled narrow-angle glaucoma and in patients who are at risk for these conditions.\n                  Oxybutynin chloride is also contraindicated in patients who have demonstrated hypersensitivity to the drug substance or other components of the product."
}